- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Tilray Stock Rises on Lockup Extension with Investor
Tilray’s surge in share price was thanks to a new agreement to extend the lockup of shares owned by investment firm Privateer Holdings.
Shares of marijuana producer Tilray (NASDAQ:TLRY) jumped in Monday’s (June 10) trading session following a special arrangement with its biggest investor to place restrictions on its shares.
According to Tilray, the special agreement with Privateer Holdings will extend the current lockup of 75 million shares of the marijuana company, so if a sale of shares happens it will be heavily restricted.
Tilray opened on Monday at a price of US$44.26. The stock finished the day with an increase of 14.88 percent from the previous day’s close to reach a price point of US$44.57.
In this transaction, Tilray will acquire Privateer in what is referred to as a downstream merger. Once the acquisition goes through, Tilray will issue Privateer shareholders the same number of its own shares that they currently own.
The resulting new shares will be placed in a lockup and only allowed for sale in special conditions over a two year period.
During the first year, the restriction will be held except for “marketed offerings and/or block trades to institutional investors or via stock sales to strategic investors.”
Privateer financed Tilray’s early days and its path to its initial public offering (IPO) on a senior US exchange in July 2018. Brendan Kennedy, CEO of Tilray, acts as executive chairman for the investment firm as well.
In May, Bloomberg issued a list of the highest-paid executives, with Kennedy securing the second position, fueled in part by the company’s meteoric rise in the stock market.
“We believe this transaction will give Tilray greater control and operating flexibility, while allowing us to effectively manage our public float,” Mark Castaneda, chief financial officer of Tilray, said in a press release.
Seattle-based investment firm Privateer holds an ownership stake of 77 percent of Tilray’s total outstanding shares.
Michael Blue, managing partner of Privateer, said the investment firm sees this deal as maximizing overall returns for its investors, while at the same time giving Tilray “the operating flexibility it needs” in its operations.
In January, Tilray reached the IPO lockup deadline for its shares, which caused the stock to drop double digits in value.
The stock of Tilray is removed from its volatile trading days during which it was a popular trading item that even reached a price of US$300 at one time in 2018.
Over a year-to-date period the company has posted a loss in value of 44.93 percent. However, since the IPO was completed in July 2018, the company has surged 30.33 percent.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.